Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: An analysis of doubly TPO- and G-CSF receptor-deficient mice

Blood

Volumn 99, Issue 10, 2002, Pages 3573-3578

  Kaushansky, Kenneth ^a   Fox, Norma ^a   Lin, Nancy L ^a   Conrad Liles, W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GROWTH FACTOR; THROMBOPOIETIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CAUSE OF DEATH; CELL LINEAGE; COLONY FORMING UNIT GM; CONTROLLED STUDY; GRANULOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INFECTION; KNOCKOUT MOUSE; MEGAKARYOPOIESIS; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PERINATAL MORTALITY; PRIORITY JOURNAL; STEM CELL; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0037093227     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3573     Document Type: Article

References (37)

1. Differentiation and proliferation of hematopoietic stem cells
2. Filgrastim (r-metHuG-CSF): The first 10 years
3. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization
4. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor deficient mice
5. Thrombopoietin: The primary regulator of platelet production
6. Thrombopoietin
7. Thrombocytopenia in c-mpl-deficient mice
8. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl
9. Low levels of erythroid and myeloid progenitors in thrombopoietinand c-mpl-deficient mice
10. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
11. Role of c-mpl in early hematopoiesis
12. Cytokine production and function in c-mpl-deficient mice: No physiologic role for interleukin-3 in residual megakaryocyte and platelet production
13. IL-3 does not contribute to platelet production in cMpl-deficient mice
14. The residual megakaryocyte and platelet production in c-Mpldeficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor
15. Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice
16. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced longterm survival
17. Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation
18. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin
19. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy
20. Glucocorticoids inhibit apoptosis of human neutrophils
21. The mouse W/c-kit locus
22. Stem cell factor improves the repopulating ability of primitive hematopoietic stem cells after sublethal irradiation (and, to a lesser extent) after bone marrow transplantation in mice
23. Clonal evolution following chemotherapy-induced stem cell depletion in cats heterozygous for glucose-6-phosphate dehydrogenase
24. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia
25. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells
26. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice
27. Low levels of erythroid and myeloid progenitors in thrombopoietinand c-mpl-deficient mice
28. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in cancer patients
29. Regulation of polymorphonuclear cell activation by thrombopoietin
30. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia
31. In vitro megakaryocytopoietic and thrombopoietic activity of c-mp/ligand (TPO) on purified murine hematopoietic stem cells
32. The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production
33. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer
34. Augmentation of megakaryocytopoiesis within the hematopoietic microenvironment of human granulocyte colony-stimulating factor transgenic mice
35. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
36. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets
37. Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors